Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Feb 07, 2024 4:35pm
186 Views
Post# 35868416

RE:RE:RE:RE:Oncy is a Cult Pt. 2

RE:RE:RE:RE:Oncy is a Cult Pt. 2
Hmm, let's see, a stock down 70% in the last year, yes that does sound familiar especially if you look at the onc ticker as that is where we also stand right now. And down 30 % in just the last week alone.
So how is that a good thing. We can defend the science all we want but can we defend the company and the BOD and people running it is the question.
As Azzak has said they are doing a lousy job so hopefully the science end will pull us through.
I am sure we will hear something now within the next couple of weeks or sooner and hopefully it will be more than just the announcement of the 4th quarter and year end financials and this should be addressed or someone should answer for it..
The possible good out of all of this is that if they are in a blackout period and something is on the table of which no one knows for sure then they cannot talk about it until something is done one way or another.
I will say it is frustrating that with being down 70% in the last 8 months that all of managment together has made a lot of money and received a lot of options with no downside risk at all so they do not share the same sentiment as shareholders. They could all walk away tomorrow millionaires and not have to answer to anyone.
So let's hope that the blackout period is for all the right reasons and that the time for shareholders can finally start looking like a biotech company that actually has 2 phase 3 ready trials as they say.
<< Previous
Bullboard Posts
Next >>